Newly Broadened 340B Patient Definition: How the Latest Genesis Court Decision Could Impact The Entire Industry
10 Specialty Drug Numbers You Need to Know for 2023
10 Fast Facts About the Pharmacy Benefits Industry
Protecting Your Clients Against Off-Label Ozempic
International Drug Sourcing: Realistic or Unreasonable?
Biosimilars, GLP-1s, and Stop-loss: Topics Benefit Advisors Need to Consider in Q3 2023
Everything you need to know about 340B in 2023
After 20 Years of Humira Prescriptions, Therapeutic Interchange Programs Give Employers Much-Needed Options
The 5 Most Expensive Gene Therapies in the U.S.
Enjoy our latest blogs, white papers and news by signing up for our newsletter today!
